New role will drive development of AI-based drug discovery software solutions and lead development team expansion
23 February, 2021
Call for volunteers to enrol in studies that will play a key part in developing effective vaccines and treatments for COVID-19
17 February, 2021
LONDON, 17 February 2021 – Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
17 February, 2021
Benjamin L. Ebert, USA, receives this year’s Sjöberg Prize, worth one million US dollars, for his research into how lenalidomide works as a treatment for blood cancer. His discovery of the mechanism that promotes protein breakdown in cancer cells may be vitally important to the future development of new pharmaceuticals.
17 February, 2021
Celltrion is on track developing a neutralising antibody cocktail with Regdanvimab (CT-P59) tailored to fight against the emerging new variants. CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant genome mutations of SARS-CoV-2. Celltrion has constructed a COVID-19 antibody portfolio and clinical development platform to help combat the spread of the virus mutations
16 February, 2021
Thursday 11th February CPI announced the signing of an agreement with PwC, making it a partner in the Medicines Manufacturing Innovation Centre collaboration. The partnership will utilise PwC’s global reach, expertise and experience within the life sciences sector to benefit patients, drive economic growth and help cement the UK as a world leader of advanced medicines manufacturing innovations.
16 February, 2021
The topic of this month’s newsletter from Drug Discovery Today is “Nanotechnology”.
08 February, 2021
A new approach to treating one of the leading causes of blindness among patients with diabetes is being tested in clinical trials which begin this month.
08 February, 2021
Stockholm, February 03, 2021: Molecular diagnostics firm Elypta announced today the launch of the first standardized testing service based on a RUO liquid biopsy for full spectrum glycosaminoglycan quantification for researchers. Elypta is also launching a sponsorship program to support more academic research in the field, prioritizing fundamental, pre-clinical, and clinical questions about how glycosaminoglycans relate to cancer.
08 February, 2021
February 4th is World Cancer Day. As Covid continues to re-shape our lives it is important to keep awareness about men’s health high. Recent news about Greg Rutherford’s detection of a cyst is a reminder that it is important for men to get regular check-ups. Testicular cancer is one of the most common forms of cancer in males and it affects around 2,300 men in the UK each year. Need2Know Books are currently offering customers a free download of The Essential Guide to Testicular Cancer. If you have concerns and questions the book provides clear and helpful advice with useful instruction and guidance on what to look for and how to do a self-examination.
03 February, 2021
Leading research materials supplier, Goodfellow, has announced it is a member of the UK-China Joint Working Group on the Graphene standardisation
02 February, 2021